chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headache; current diagnosis psoriatic arthritis; difficulty moving her arms; She also received two vaccination/and the other arm for Pneumovax/Her arm was red; She also received two vaccination two days ago for Shingrix in one arm on 14 Mar 2022, noted swelling; Chills and shivers; This spontaneous report was received from a consumer referring to a 56 year old female patient. Information regarding the patient's medical history, and concomitant medications was not provided. The patient had migraine headaches treated with historical drug sumatriptan, vision blurred, and the patient wore glasses.   On 12-MAR-2022, the patient started therapy with risankizumab(SKYRIZI) 150 mg solution for injection in pre-filled pen at a total daily dose of 150 mg by subcutaneous route (lot number and expiration date were not reported) for psoriatic arthritis (off label use). On 13-MAR-2022, the patient experienced headache (not specified as migraine, and not reported if treatment with sumatriptan was restarted). On 14-MAR-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and  varicella zoster vaccine rge (cho)(SHINGRIX) for prophylaxis (doses, routes of administration, vaccination scheme frequency, lot numbers and expiration dates were not reported) in the arms (not specified which vaccine in which arm). On unspecified date in March 2022, the patient experienced chills and shivers, and physician was unaware. Besides, after the vaccinations, she noted swelling in the arm where she was vaccinated (vaccination site swelling), her arm was also red (vaccination site erythema ), and had difficulty moving both arms (vaccination site movement impairment). On 16-MAR-2020, she would have a physician appointment. The action taken with the suspect vaccines was not applicable; therapy with risankizumab (SKYRIZI) was continued. The outcome of the events was unknown.   Causality assessment with risankizumab(SKYRIZI), pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and  varicella zoster vaccine rge (cho)(SHINGRIX) and the events was not provided. However, the headache was considered to be not related to pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and  varicella zoster vaccine rge (cho)(SHINGRIX)as it happened before the start of these therapies.
This spontaneous report as received from a pharmacy technician refers to a male patient of unknown age. On 26-AUG-2014 the patient was vaccinated intramuscularly with PNEUMOVAX 23 (injection, 0.5 ml, once) (lot # reported as K004483, exp date: 16-AUG-2015). In approximately 26-AUG-2014 (specific date not provided) the patient experienced abscess at the PNEUMOVAX 23 injection site. On 27-AUG-2014, he was admitted to the hospital and had not yet been discharged (reported as had not been discharged "as of today"). The outcome of abscess at the PNEUMOVAX 23 injection site was unknown. The relatedness between the event and PNEUMOVAX 23 was not reported. Additional information has been requested.
intense pruritus bilateral axillae, with progressive rash from  bilateral axillae to neck and up behind ears. axillary lymphadenopathy, headache, dizziness.
Brachial Plexus neuritis.  2/16/07 Received medical records from reporter/provider which reveal patient experienced immediate pain at time of vax within the left shoulder girdle extending down into the elbow & into the scapular region.  Had neuro evals x 2: 1/2/07 Neuro eval revealed continued difficulty with external rotation of left shoulder girdle, forward flexion & extension.  Sleep was affected.  Exam revealed mild weakness of suprascapular innervated nuscles, axillary innervated muscles & borderline long thoracic nerve weakness.  DTRs were 1/5 & symmetrical.  Decreased pinprick in axillary nerve distribution.  FINAL DX: left brachial amyotrophy involving both suprascapular & axillary nerves, most likely autoimmune; & perimenstrual migraines w/probable comorbidities. EMG & MRI were recommended.  Placed on steroids. 2/6/07 2nd Neuro eval revealed complaints of gradual buildup of pain in left deltoid w/swelling & discoloration & pain moved up into shoulder blade as shooting pain w/certain movements.  Left arm weakness as well as pain.   Patient had not done the EMG/NCS or MRI as recommended.  Exam revealed no tenderness to palpation of left arm or shoulder w/full ROM & no scapular winging.  There was a mild difference in pinprick sensation in left axillary nerve distribution. FINAL DX: probable left brachial plexus neuritis, mild, most likely idiosyncratic immune mediated reaction to flu vax.  Recommended to avoid flu shots in future.  OT was recommended.  Patient deferred EMG/NCS.   FINAL DX of 2 neurologists: left brachial plexus neuritis, most likely idiosyncratic immune mediated reaction to flu vax.
Patient experienced severe arm pain lasting for 6 days. Likely due to injection error (near scapula)
This spontaneous report as received from a nurse practitioner refers to a female patient of unknown age with a family history of autoimmune disorders. On an unknown date the patient was vaccinated with GARDASIL injection (dose, route and lot# not reported). It was reported that the patient experienced joint pain, two months after receiving GARDASIL. The outcome of joint pain was unknown. This is one of the several reports from the same reporter. Additional information has been requested.
pt recv vax 17OCT96 & exp gen muscle weakness & fever of 102;pt had gen muscle weakness & macular facial rash;7JAN97 pt was adm to hosp because of poor swallowing & aspiration;started on med;
About 20 seconds after being give the flu vaccine pt. slumped to the side, became very pale, sweating profusely, nauseous, weak an dizzy. Pt. began feeling better after a few minutes.
Pt c/o (R) lateral thigh, reddened, hard, warm to touch, swollen with slight bruise - 930am. Treatment: pt to take MOTRIN prn.
>50 erythematous papules on torso/neck/ext. some after vesicles and crust.
Prevnar/TDAP was given 04/07/08.  Local erythema and edema noted.  Tennis ball size.  Both vaccines given proximal to each other.
Contacted pharmacy on 11/21/20, and patient said injection site became sore, red and inflamed, advised to warm pack for 24 hours and contact physician if not markedly improved. Patient went to see physician on 11/24/20 and was diagnosed with cellulitis and put on a course of cephalexin.
Less than 24 hours after receiving shot, this patient developed soreness, tenderness around injection site. Became inflamed, red/ swollen area which progressively spread down his arm and through out his shoulder. Admitted to the local hospital, work up for septic arthritis (-) did aspirations showing (+) WBC. Placed on antibiotics and steroids.  Discharged after 72 hours home.  diagnosed with acute synovitis in left ahoulder
Patient experienced swelling of lips and itching sensation in her throat 20 minutes after receiving her 2nd dose. Called EMS to her vehicle. Transport ambulance was called to bring patient to ER. Benadryl 50mg IM given by onsite EMS prior to transport.
Allergic reaction, blood pressure spike, heart rate increase, fever, throat tightened. Benegryl; Few seconds to start to take affect. Benegryl controlled till reaction was over
Myalgia 1st dose: discomfort, swelling, tenderness, muscle pain at injection site and swollen glands Narrative:  Dose #1:discomfort, swelling,tenderness,muscle pain at injection site and swollen glands
I received the Pfizer Bivalent booster on 9/8/2022. On the evening of 11/24/2022, I had congestion, sneezing, and a slight scratchy throat. The symptoms continued until 11/26/2022, when I took a home antigen test, which yielded a positive result. I then began taking PAXLOVID. The symptoms improved within 12 hours of beginning the PAXLOVID treatment. I tested the morning of 11/28/2022 and got a positive result. I tested again that evening and got a negative result. I was able to return to work on 11/29/2022.
Fever 101.5, light-headedness, moderate to severe muscle and joint aches, headache, tiredness, lethargy.  Symptoms lasted approximately 24 hrs.  Ibuprofen (400mg) helps with symptoms.
PT EXP PAIN AND STINGING AT SOI AFTER RECEIPT OF ENGERIX-B.  TREATMENT:  PT COUNSELING.  DOSE #2 13Jan90 PT EXP SAME SYMPTOMS.
Information has been received from a registered nurse referring to a patient of unknown age and gender on 20-OCT-2017. There was no information about patient's concurrent conditions, medical history or concomitant medications. On 17-OCT-2017, the patient was vaccinated with improperly stored VARIVAX lot # N012131 and expiration date of 17-APR-2019, (route of administration and anatomical location were not reported) for prophylaxis, reconstituted with properly stored sterile diluent (MERCK STERILE DILUENT) (lot # unknown), The vaccines were stored in the range of 6 Farenheit degrees to 14 Farenheit degrees for 3 hours and 40 minutes. No previous temperature excursion was reported. The patient did not experience any adverse events. Digital data logger was involved. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1710USA014744: US-009507513-1710USA014745: US-009507513-1710USA014746: US-009507513-1710USA014747: US-009507513-1710USA014748: US-009507513-1710USA014749: US-009507513-1709USA007342:
The pt developed lightheadedness and wheezing, 5 and 10 minutes respectively, post vax. The pt has a medical history of asthma. Follow-up information was received and the pt was treated with asthma medications shortly after wheezing occurred. The pt recovered.
December 15th. Pt noticed paralysis in facial muscles. Thought he was having a stroke and went to emergency room. Diagnosed with Bell's Palsy. Is being treated with ACYCLOVIR and PREDNISONE. Bell's Palsy has not completely resolved as of 12-23-09.
Pt c/o very sore arm/muscle after the vaccine and it has continued, only hurts at the injection site.
Fever started about 8 hours after the second dose. Peaked at 100.2.  It lasted around 12 hours after that before it dissipated.
A day after the vaccination I experienced a dirty (is the only way I can describe) feeling of some kind of toxin coming out of my skin mainly the worst in my hands but through out my body as well. I describe it as a shedding feeling with such a NASTY feeling on my skin. Shortness of breath and heart pain.
The day after receiving my Pfizer vaccine I experienced fever, chills, body aches and other flu like systems. I have been in bed about a day and a half using Tylenol to manage headaches and fever, and advil for body aches and muscle cramps.
malaise, cough, headache, fever, muscle aches, without rash only 2 days after a primary vaccination (3 jabs)  clinical dx an unrelated flu like syndrome
2 hours after injection:-  Sore arm.  12 hours-99 degree temp, elevated pulse, shivers. 14 hours-100 degree temp, elevated pulse (120 bpm), chills, persistent moderate headache, achy muscles, sore back. 24 hours-98 degree temp, head ache gone, just a worn out feeling, 36 hours-back to normal other than a very sore arm at injection site and a worn out feeling.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 25-JUN-2015 the patient was vaccinated with ROTATEQ (dose was not reported, route of vaccination defaulted to oral, lot # K013661 with expiration date: 25-JUN-2016) which was improperly stored. No adverse symptoms reported. This is one of several reports from the same reporter. Additional information has been requested.
Pt has swollen arm tendon and limited range of motion - reaction recognized about 5 days after immunization. Pt is taking meds and physical therapy.
Rash around arm, itching - started 10-17-15 trouble breathing. Went to urgent care on 10-20-15 given prednisone and albuterol.
3/3/2021--called to report an adverse reaction to her 2nd dose of Pfizer COVID-19 Vaccine received on 2/25/2021. She reports she had extreme pain and achiness on her whole L side (arm she received vaccine in) from her head to her toes. The next morning her daughter called and she had temporary dysphasia (she lives alone and had not tried to speak at all until then). Daughter took her to the Instacare and then the hospital - she stayed at the hospital through the day and received IV fluids and the dysphasia occurred again while there but has not happened again since. LSW, RN.
Taste and smell of Fruits vegetables, soaps, fragrance smells like ammonia or weird smell and taste
Client at COVID vaccine clinic POD to receive booster dose of Pfizer. Client inadvertently given 0.25 ml instead of the full 0.3 ml. Per CDC guidance, client notified of error and full dose immediately administered in opposite arm. Monitored for full time with no sign of reactions.
Very sore arm (almost unusable), chills, shaking, high fever (102.5), loss of appetite.  Lasted almost 24 hours.
pt recvd vax;sxs included entire arm redness & swelling, dec in range of motion w/ pain, fever, site hot to touch; tx w/ advil, ice, arm elevation;
pt recvd vax & 18JAN96 5wks p/vax had inc leg pain, joint pain & aches, arms, back of neck, shoulder, lower back aches, nausea & diarrhea w/light colored stools & total of 6# weight loss;
VACCINE WAS GIVEN AT 11:00 AM ON THURSDAY, JULY 24, 2008.  FATIGUE BEGAN AT 12:00 NOON. FEVER 102.5, BODY ACHES AND JOINT PAIN FIRST NOTICED ABOUT 4:00 PM THE SAME DAY.  FEVER AND PAIN DECREASED WITH THE USE OF ADVIL, TYLENOL AND ALEVE COMBINED.  AS MEDICATION WORE OFF, FEVER ANS ACHES RETURN. PAIN AND NIGHT SWEATS, AND STAYED AWAKE UNTIL 4:00AM.  WENT BACK TO DR. ON FRIDAY 7/25/08 AT 3:15PM.  STILL HAD FEVER AND ACHES, WAS TOLD BY DR. TO CONTINUE TYLENOL.  FEVER AND ACHES CONTINUE TO DECREASE WITH USE OF TYLENOL, BUT RETURNS AS SOON AS TYLENOL WEARS OFF, EVERY 3-4 HRS THRU FRIDAY NIGHT, SAT. 7/26/08 AND CURRENTLY SUN 7/27/08.
hearing loss in both ears; hypersensitive to sound; painful; trouble sleeping; tinnitus; tinnitus; This is a spontaneous report from a contactable consumer (patient).  A 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on Mar2021 16:00 (Batch/Lot Number: er8727), age at vaccination of 62-years-old, as single dose, dose 2 via an unspecified route of administration, administered in Arm Left on 15Apr2021 10:00 (Batch/Lot Number: ew0151), age at vaccination of 62-years-old, as single dose for covid-19 immunisation.  Medical history included asthma from an unknown date and unknown if ongoing (mild asthma), drug hypersensitivity from an unknown date and unknown if ongoing (allergies: sulfa drugs), tinnitus from an unknown date and unknown if ongoing (mild tinnitus diagnosed 10 years ago), deafness from an unknown date and unknown if ongoing (diagnosed 10 years ago). The patient received tetanus vaccine in left arm on 12Mar2021 within 4 weeks prior to the COVID vaccine (age at vaccination of 62-years-old). The patient was not pregnant and was not pregnant at the time of vaccination. Concomitant medications included pantoprazole (PANTOPRAZOLE) taken for an unspecified indication, start and stop date were not reported; levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported; losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported and hormone replace taken for an unspecified indication, start and stop date were not reported After the vaccine (both doses) tinnitus rose exponentially, and patient was diagnosed with hearing loss in both ears. Not sure when the additional hearing loss took place. The patient also become hypersensitive to sound, it was almost painful. The patient had trouble sleeping, listening to tv, music, going out to restaurants, etc because of this reaction. ENTs can only recommend hearing aids. After 9 weeks tinnitus has quieted a little bit but not back to pre vaccine level. The events resulted in doctor or other healthcare professional office/clinic visit. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Treatments were given for the events (after first vaccine took a course of prednisone). Outcome for the events was unknown.  Follow-up attempts are possible. Further information is expected.
Pink, non-raised, generalized rash over abdomen, back, eyes, ears and spotty at legs and arm. Temperature 101.4F.
General malaise beginning approximately 2 hours after dosage, rash on neck traveling to faces chest and arms 2 hours , headache around 2.5-3 hrs , body aches and inability to concentrate or focus well 5-6 hours after administered Severe fatigue started 8-9 hours after administering vaccine- I literally fell asleep trying to eat supper after work and I slept without waking or stirring from may16 9:30 pm - may 17 12:45 pm woke only to urinate and call into work back asleep in under and hour - slept again until 8:45 pm only woke for significant other for welfare check  and if I wanted to eat - I couldn?t stay awake and slept solid until may18 4:44 am at which time I urinated and grabbed a drink and a snake which I fell asleep eating - I continues to sleep until 3:30 pm at which time I got up and dressed NOTICED bruises all over my body mostly small like a pencil eraser size with a few quarter to silver dollar size bruises on my inner thighs and right calf - I also had numerous skin lesions that were the size of a pin head but also leasions appeared where scaring or healed lesions were and they were seeping - my headache still continued- as long as I move around I stay awake but if I sit I fall asleep immediately. I stayed awake for 5-6 hours may 18 but slept 12 hours solid asking may 19 8:30 am I had to attend to some business and legal matters then had graduation in the evening I did nothing. Strenuous other than shower- I seem to feel better until I attend graduation and  hit the grocery store I was o it from 6pm-10pm and I felt like hell  ? this is the general pattern still until I called dr and saw doc ondemand who noticed the bruising and sent me to ER for blood work which reveals low rbc, platelets , hemoglobin and slow clotting times they simply sent me home but to follow up in 2 days with pcp
Patient received flu shot 9/24/07 reported hoarse/wheeze/sob 10/6/07 hospitalized 10/12/07 released 10/18/07.  11/9/07 Reviewed hospital medical records which reveal patient experienced SOB, DOE, wheezing, progressive chest tightness, nausea, weakness, productive cough, sore throat, hoarseness & weight loss of 5-6 # over 2 weeks. Admitted 10/12-10/17/2007.  Pulmonary, ENT, GI & cardiac consults.  FINAL DX: Acute bronchitis.
Patient was asymptomatic and presented with a cardiac arrest, found to have a wide complex rhythm.  Shocked x2 with ROSC.
The child developed periorbital edema, generalized facial swelling, generalized rash with drooling. approximately 30 minutes post vax. No wheezing was observed. Treated in ER with steroids and Benadryl.
This spontaneous report as received from medical assistant refers to multiple unspecified patients of unknown age and gender. Information on pertinent medical history and concurrent condition was not provided. On an unspecified dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # N004799, expiry 15-NOV-2019 (dose and route not reported) for prophylaxis. It was reported that on unspecified dates, the vaccine was exposed to a temperature between 2 Centigrade degrees and 8 Centigrade degrees (1.8C) for 42 minutes. There was previous temperature excursion between 0 Centigrade degrees and 1 Centigrade degree for 1 hour and 56 minutes and another excursion between 9 and 25 Centigrade degrees (11.4C) for 1 hour and 41 minutes. The call was placed because of a Digital Data logger report. No adverse effects reported. As of 01-SEP-2017, all telephone attempts to obtain follow up information had been unsuccessful. Follow up information has been received from the medical assistant on 05-SEP-2017. The patient's age was confirmed as 14 years. It was also confirmed that on 25-JUL-2017 the patient was vaccinated with the improperly stored GARDASIL 9 lot # M044717 (previously reported as lot # N004799). This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA005737: US-009507513-1709USA005738: US-009507513-1709USA005747: US-009507513-1709USA005740: US-009507513-1709USA005741: US-009507513-1709USA005742: US-009507513-1709USA005743: US-009507513-1708USA001768: US-009507513-1709USA005745: US-009507513-1709USA005746: US-009507513-1709USA005736: US-009507513-1709USA005735: US-009507513-1709USA005748: US-009507513-1709USA005739.
Information has been received regarding a case in litigation, from a lawyer, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unspecified date in 2015, the patient was vaccinated with ZOSTAVAX, due to health care professional recommendation, for permanent prevention and protection against shingles and zoster-related injuries (prophylaxis) (strength, anatomical location, dose, route of administration, lot # and expiration date were not provided). On an unknown date, on or about 02-NOV-2016, the patient was treated by a physician for shingles, as the patient was diagnosed with shingles or other related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient had and would continue suffer ongoing injuries, included but not limited to: mental and physical pain and suffering, extensive medical care and treatment for these injuries; significant medical an related expenses as a result of these injuries, included but not limited to medical losses and cost include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions. At the time of report, the patient was not recovered from emotional distress, injury and pain. The outcome of vaccination failure, quality of life decreased, herpes zoster and the pre-existing unspecified conditions aggravated was unknown. The reporter considered the events to be disabling, life-threatening and medically significant.
pt screamed & cried x 5 or 6 hrs p/vax 29DEC93;
p/vax pt exp varicella of a mild nature w/less than 30 lesions;
103F AX in 24 hrs p/4mo DTP; Had apnea alarms p/1st DTP but had apnea of prematurity according to mom; 10MAY91 admitted for RSV;